UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
OPERATING ACTIVITIES
Net income including non-controlling interest	$ 17,720	$ 11,712	$ 31,188	$ 23,329
Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:
Depreciation and amortization			11,924	8,609
Provision for credit losses	1,995	1,717	3,843	3,344
Equity-based awards compensation expense			3,888	3,916
Amortization of debt issue costs			210	210
Change in deferred income taxes			7,279	770
Change in revaluation of put-right liability	339	223	743	303
Change in fair value of contingent earn-out consideration	(790)	4,046	(5,612)	3,434
Equity of earnings in unconsolidated affiliate	(401)	(248)	(794)	(519)
Loss on sale of fixed assets			438	51
Loss on sale of a partnership	0	0	123	0
Changes in operating assets and liabilities:
Patient accounts receivable, net			(10,232)	(5,110)
Accounts receivable - other			355	(2,351)
Other current and long term assets			(4,426)	(1,642)
Accounts payable and accrued expenses			(7,914)	(1,481)
Other long-term liabilities			(827)	548
Net cash provided by operating activities			30,186	33,411
INVESTING ACTIVITIES
Purchase of fixed assets			(5,830)	(4,174)
Purchase of majority interest in businesses, net of cash acquired			(6,890)	(38,695)
Purchase of redeemable non-controlling interest, temporary equity			(8,427)	(6,230)
Purchase of non controlling interest, permanent equity			(149)	(527)
Proceeds from the sale of non-controlling interest, permanent equity			9	26
Proceeds from the sale of partnership interest - redeemable non-controlling interest, temporary equity			15	69
Repayment of notes receivable related to redeemable non-controlling interest			346	375
Proceeds from the sale of partnership			700	0
Distributions from unconsolidated affiliate			664	532
Other			228	(131)
Net cash (used in) investing activities			(19,334)	(48,755)
FINANCING ACTIVITIES
Proceeds from revolving facility			73,500	0
Payments on revolving facility			(60,000)	0
Distributions to non-controlling interest, permanent and temporary equity			(10,697)	(8,318)
Cash dividends paid to shareholders			(13,678)	(13,264)
Payments on term loan			(5,625)	(1,875)
Principal payments on notes payable			(1,628)	(1,113)
Net cash (used in) financing activities			(18,128)	(24,570)
Net (decrease) in cash and cash equivalents			(7,276)	(39,914)
Cash and cash equivalents - beginning of period			41,362	152,825	$ 152,825
Cash and cash equivalents - end of period	$ 34,086	$ 112,911	34,086	112,911	$ 41,362
Cash paid during the period for:
Income taxes			9,833	4,932
Interest paid			4,683	3,708
Non-cash investing and financing transactions during the period:
Purchase of businesses - seller financing portion			0	955
Fair market value of initial contingent consideration related to purchase of businesses			3,059	2,800
Offset of notes receivable associated with purchase of redeemable non-controlling interest			254	75
Notes payable related to purchase of non-controlling interest, temporary equity			0	22
Notes payable related to purchase of redeemable non-controlling interest, temporary equity			89	0
Notes receivable related to sale of redeemable non-controlling interest, temporary equity			660	402
Notes receivable related to the sale of non-controlling interest, permanent equity			$ 29	$ 243